Saltar al contenido
Merck

XRCC1 mediated the development of cervival cancer through a novel Sp1/Krox-20 swich.

Oncotarget (2017-11-22)
Qingtao Meng, Shizhi Wang, Weiyan Tang, Shenshen Wu, Na Gao, Chengcheng Zhang, Xiaoli Cao, Xiaobo Li, Zhengdong Zhang, Michael Aschner, Hua Jin, Yue Huang, Rui Chen
RESUMEN

Cervical cancer is the second leading cause of mortality among women. Impairment of the base excision repair (BER) pathway is one of the major causes of the initiation and progression of cervical cancer. However, whether the polymorphisms of the BER pathway components (i.e.,

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Suplatast tosylate, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human EGR2